Form 4: Centene Director Wayne S. DeVeydt Reports Acquisition of Common Stock

Wayne S. DeVeydt, a director of Centene Corp, reported acquiring 541 shares of common stock on March 31, 2025.

Summary

• On March 31, 2025, Wayne S. DeVeydt, a director at Centene Corp, acquired 541 shares of common stock.
• The acquisition was made at a price of $0 per share.
• Following the transaction, DeVeydt's direct ownership in Centene Corp amounts to 15,342.274 shares of common stock, which includes 2,916 shares of restricted stock units subject to vesting requirements.
• DeVeydt also holds options to buy 10,000 shares of common stock at an exercise price of $80.57, exercisable from February 7, 2025, and expiring on February 7, 2032.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, indicating a neutral sentiment. It simply reports a transaction without expressing any positive or negative outlook.

Industry Context

This filing is a routine disclosure of a director's stock transactions, which is common in the healthcare industry. It provides transparency to investors regarding the alignment of management's interests with shareholders.

Comparison to Industry Standards

• Director stock ownership is a common practice across publicly traded companies, including Centene's competitors like UnitedHealth Group (UNH) and Anthem (ANTM).
• The level of ownership and option grants are generally aligned with industry standards for executive compensation and incentivization.
• Form 4 filings are standard practice and ensure compliance with SEC regulations, similar to filings made by directors and officers at other major healthcare companies.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding director's stock ownership.
• It can influence investor perception of management's confidence in the company.

Key Dates

Keywords

Centene Corp, Director, Wayne S. DeVeydt, Common Stock, Acquisition, Form 4, Beneficial Ownership, Options, Restricted Stock Units